A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase

Por Stagni, Venturina, Santini, Simonetta, Barilà, Daniela
Publicado em 2012

ITCH E3 ligase in ATM network

Por Stagni, Venturina, Santini, Simonetta, Barilà, Daniela
Publicado no Oncoscience (2014)

ATM kinase activity modulates ITCH E3-ubiquitin ligase activity

Por Santini, Simonetta, Stagni, Venturina, Giambruno, Roberto, Fianco, Giulia, Di Benedetto, Anna, Mottolese, Marcella, Pellegrini, Manuela, Barilà, Daniela
Publicado em 2013

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells

Por Presutti, Dario, Santini, Simonetta, Cardinali, Beatrice, Papoff, Giuliana, Lalli, Cristiana, Samperna, Simone, Fustaino, Valentina, Giannini, Giuseppe, Ruberti, Giovina
Publicado no PLoS One (2015)

Proteomic profiling of ATM kinase proficient and deficient cell lines upon blockage of proteasome activity()

Por Marzano, Valeria, Santini, Simonetta, Rossi, Claudia, Zucchelli, Mirco, D'Alessandro, Annamaria, Marchetti, Carlo, Mingardi, Michele, Stagni, Venturina, Barilà, Daniela, Urbani, Andrea
Publicado em 2012